Keep innovating to help renew the quality of human life.
Hunan Ouya Pharmaceutical Co., Ltd (hereinafter referred to as "OUYA") was established in 2007 and is located in Liuyang Economic and Technological Development Zone, Hunan Province, with a total land area of more than 160 mu. It is a high - tech enterprise focusing on the R & D, manufacturing and sales of APIs (Active Pharmaceutical Ingredients) and pharmaceutical intermediates in the fields of cardiovascular,anti-cancer and anti - virus, etc. OUYA obtained the Drug Production License in 2019. Currently, it has two modern production sites (both have GMP certification), an independent anti - cancer production line and several multi - functional product lines.
Over the passed 17 years,OUYA has adhered to the concept of "Technology - oriented, Environmental Protection and Health", and is committed to providing efficient, safe, green and one - stop CDMO/CMO solutions for global pharmaceutical enterprises. Since 2019, relying on the core leading technologies such as asymmetric synthesis, grignard reaction, redox reaction, and a quality management system complied with international GMP standards, we have successfully developed and applied for nearly 20 APIs and excipients to the CDE (Center for Drug Evaluation), and have established long-term and strategic cooperation with many well - known global pharmaceutical enterprises.
The standardized quality system and continuously innovated technology enable the product quality always to be at the leading level in the industry.
Establish a complete whole - industry chain, optimize production efficiency, and effectively and reasonably control production costs.-->and control the production cost effectively
Focus on regulated markets and cooperate with customers worldwide with an open attitude.